product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
c-Cbl (D4E10) Rabbit mAb
catalog :
8447
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
D4E10
reactivity :
human, mouse, rat
application :
western blot, immunoprecipitation, immunohistochemistry - paraffin section
citations: 1
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 2a
Cen O, Kannan K, Huck Sappal J, Yu J, Zhang M, Arikan M, et al. Spleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated Lymphoma. mSphere. 2018;3: pubmed publisher
product information
SKU :
8447S
Product-Name :
c-Cbl (D4E10) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Mk
Applications :
Immunoprecipitation
Product-Category :
Ubiquitin and Ubiquitin-like proteins
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
120
Host :
Rabbit
Target :
Cbl
Primary-Protein :
Cbl
Alt-Names :
C-CBL,CBL,CBL2,Cas-Br-M (murine) ecotropic retroviral transforming sequence,Casitas B-lineage lymphoma proto-oncogene,E3 ubiquitin-protein ligase CBL,Proto-oncogene c-Cbl,RING finger protein 55,RNF55,Signal transduction protein CBL,oncogene CBL2
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.